搜索临床试验以:MH004 Ib-1(0.3%)
总计633个结果
-
Herlev and Gentofte HospitalGöteborg University; University of Copenhagen; Sahlgrenska University Hospital, Sweden完全的
-
NeuroHealing Pharmaceuticals Inc.Michael J. Fox Foundation for Parkinson's Research完全的
-
National Institute of Hygiene and Epidemiology,...Ministry of Health, Vietnam; Ministry of Science and Technology, Vietnam完全的
-
Can-Fite BioPharma终止
-
Otsuka Beijing Research Institute招聘中
-
Southeast Retina Center, GeorgiaGenentech, Inc.完全的
-
The First Affiliated Hospital with Nanjing Medical...Wu Jieping Medical Foundation完全的
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.邀请报名
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna未知
-
Shulov Innovate for Science Ltd. 2012招聘中
-
Ceylan SaygiliIstanbul University - Cerrahpasa (IUC)完全的
-
Galderma R&D完全的健康受试者,男性或女性,年龄在 18-60 岁之间,照片类型为 I、II 或 III,未预处理/预处理皮肤法国
-
Sichuan Haisco Pharmaceutical Group Co., LtdSecond Affiliated Hospital, School of Medicine, Zhejiang University完全的
-
University of OxfordNIHR Oxford Health Biomedical Research Centre尚未招聘
-
MedImmune LLCAstraZeneca终止系统性红斑狼疮美国, 墨西哥, 秘鲁, 南非, 加拿大
-
Reata, a wholly owned subsidiary of BiogenAbbVie完全的
-
University Hospital, Caen完全的